Raymond James Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,208
| Closed | -$283K | – | 1165 |
|
|
2021
Q4 | $283K | Sell |
3,208
-449
| -12% | -$39.6K | 0.01% | 924 |
|
|
2021
Q3 | $283K | Buy |
3,657
+236
| +7% | +$18.3K | 0.01% | 877 |
|
|
2021
Q2 | $285K | Sell |
3,421
-3
| -0.1% | -$250 | 0.01% | 875 |
|
|
2021
Q1 | $259K | Sell |
3,424
-442
| -11% | -$33.4K | 0.01% | 894 |
|
|
2020
Q4 | $339K | Buy |
3,866
+445
| +13% | +$39K | 0.01% | 714 |
|
|
2020
Q3 | $260K | Sell |
3,421
-88
| -3% | -$6.69K | 0.01% | 756 |
|
|
2020
Q2 | $433K | Buy |
3,509
+232
| +7% | +$28.6K | 0.02% | 511 |
|
|
2020
Q1 | $277K | Buy |
+3,277
| New | +$277K | 0.02% | 572 |
|